Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    Kava | NCCAM
Show Display Options
RSS Create an RSS feed from your search for:
Kava | NCCAM
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Terminated Kava Kava for the Treatment of Generalized Anxiety Disorder (GAD)
Condition: Anxiety Disorders
Interventions: Drug: Venlafaxine ER;   Drug: Sugar pill;   Drug: Kava

Indicates status has not been verified in more than two years